With digital disruption, declining access to physicians, and the increasing appetite from healthcare professionals for readily available digital information, many have speculated on the “death of the pharma sales rep”. In this article, Veeva’s Jan van den Burg argues that as the industry shifts towards intelligent engagement, the role may prove more valuable than ever.
